Activated charcoal revisited

Clinical Pediatric Emergency Medicine

Volumn 6, Issue 2, 2005, Pages 76-80

  Gaudreault, Pierre ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Activated charcoal; Gastrointestinal tract; Toxic substances

Indexed keywords

ACETYLSALICYLIC ACID; ACID; ACTIVATED CARBON; ALCOHOL; ALKALI; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CYANIDE; DAPSONE; DEXTROPROPOXYPHENE; DIGITALIS; DIGOXIN; INORGANIC COMPOUND; IPECAC; IRON; LITHIUM; MERCURIC CHLORIDE; OPIATE; ORGANIC COMPOUND; PARACETAMOL; PHENOBARBITAL; PHENYLBUTAZONE; PIROXICAM; QUININE; SOTALOL; THEOPHYLLINE; TOXIC SUBSTANCE;

ARTICLE; CONSTIPATION; DIARRHEA; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INTOXICATION; DRUG OVERDOSE; FATALITY; GASTROINTESTINAL ABSORPTION; HUMAN; HYPERMAGNESEMIA; HYPERNATREMIA; INTESTINE OBSTRUCTION; INTESTINE PSEUDOOBSTRUCTION; INTOXICATION; PERITONITIS; SINGLE DRUG DOSE; VOMITING;

EID: 21644455605     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpem.2005.04.005     Document Type: Article

References (72)

1. A. Andersen Experimental studies on the pharmacology of activated charcoal: I. Adsorption power of charcoal in aqueous solutions Acta Pharmacol 2 1946 69-78
2. P.A. Chyka D. Seger Position statement: Single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists J Toxicol Clin Toxicol 35 1997 721-741
3. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning J Toxicol Clin Toxicol 37 1999 731-751
4. L.E. Holt P.H. Holz The black bottle: A consideration of the role of charcoal in the treatment of poisoning in children J Pediatr 63 1963 306-314
5. S.M. Bradberry J.A. Vale Multiple-dose activated charcoal: A review of relevant clinical studies J Toxicol Clin Toxicol 33 1995 407-416
6. P.J. Neuvonen Clinical pharmacokinetics of oral activated charcoal in acute intoxications Clin Pharmacokinet 7 1982 465-489
7. T.E. Albertson R.W. Derlet G.E. Foulke et al. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions Ann Emerg Med 18 1989 56-59
8. N.A. Buckley I.M. Whyte D.L. O'Connell A.H. Dawson Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose J Toxicol Clin Toxicol 37 1999 753-757
9. K. Kulig D. Bar-Or S.V. Cantrill et al. Management of acutely poisoned patients without gastric emptying Ann Emerg Med 14 1985 562-567
10. J.W. Campbell P.A. Chyka Physicochemical characteristics of drugs and response to repeat-dose activated charcoal Am J Emerg Med 10 1992 208-210
11. P.A. Chyka J.E. Holley T.D. Mandrell P. Sugathan Correlation of drug pharmacokinetics and effectiveness of multiple-dose activated charcoal therapy Ann Emerg Med 25 1995 356-362
12. A. McLuckie A.M. Forbes K.F. Ilett Role of repeated doses of oral activated charcoal in the treatment of acute intoxications Anaesth Intensive Care 18 1990 375-384
13. W.J. Decker H.F. Combs D.G. Corby Adsorption of drugs and poisons by activated charcoal Toxicol Appl Pharmacol 13 1968 454-460
14. F.D. Favin W. Klein-Schwartz G.M. Oderda S.R. Rose In vitro study of lithium carbonate adsorption by activated charcoal J Toxicol Clin Toxicol 26 1988 443-450
15. A. Minocha D.A. Herold J.T. Barth et al. Activated charcoal in oral ethanol absorption: Lack of effect in humans J Toxicol Clin Toxicol 24 1986 225-234
16. P.J. Neuvonen K.T. Olkkola Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses Med Toxicol Adverse Drug Exp 3 1988 33-58
17. R.J. Lambert B.L. Kindler D.J. Schaeffer The efficacy of superactivated charcoal in treating rats exposed to a lethal oral dose of potassium cyanide Ann Emerg Med 17 1988 595-598
18. K.T. Olkkola P.J. Neuvonen Do gastric contents modify antidotal efficacy of oral activated charcoal? Br J Clin Pharmacol 18 1984 663-669
19. P.J. Neuvonen K.T. Olkkola T. Alanen Effect of ethanol and pH on the adsorption of drugs to activated charcoal: Studies in vitro and in man Acta Pharm Toxicol 54 1984 1-7
20. A. Andersen Experimental studies on the pharmacology of activated charcoal: II. The effect of pH on the adsorption by charcoal from aqueous solutions Acta Pharmacol 3 1947 199-218
21. A. Andersen Experimental studies on the pharmacology of activated charcoal: III. Adsorption from gastric contents Acta Pharmacol 4 1948 275-284
22. M. Tenenbein S. Cohen D.S. Sitar Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose Ann Emerg Med 16 1987 838-841
23. G. Levy T. Tsuchiya Effect of activated charcoal on aspirin absorption in man: Part I Clin Pharmacol Ther 13 1972 317-322
24. G.A. Filippone S.S. Fish P.G. Lacouture et al. Reversible adsorption (desorption) of aspirin from activated charcoal Arch Intern Med 147 1987 1390-1392
25. K.C. Osterhoudt D. Durbin E.R. Alpern F.M. Henretig Risk factors for emesis after therapeutic use of activated charcoal in acutely poisoned children Pediatrics 113 2004 806-810
26. C.L. Dorrington D.W. Johnson R. Brant The frequency of complications associated with the use of multiple-dose activated charcoal Ann Emerg Med 41 2003 370-377
27. C.G. Elliott T.V. Colby T.M. Kelly H.G. Hicks Charcoal lung. Bronchiolitis obliterans after aspiration of activated charcoal Chest 96 1989 672-674
28. T. Givens M. Holloway S. Wason Pulmonary aspiration of activated charcoal: A complication of its misuse in overdose management Pediatr Emerg Care 8 1992 137-140
29. J.R. Justiniani R. Hippalgaonkar L.O. Martinez Charcoal-containing empyema complicating treatment for overdose Chest 87 1985 404-405
30. D.G. Menzies A. Busuttil L.F. Prescott Fatal pulmonary aspiration of oral activated charcoal BMJ 297 1988 459-460
31. M.M. Pollack B.S. Dunbar P.R. Holbrook A.I. Fields Aspiration of activated charcoal and gastric contents Ann Emerg Med 10 1981 528-529
32. P.J. Mariani N. Pook Gastrointestinal tract perforation with charcoal peritoneum complicating orogastric intubation and lavage Ann Emerg Med 22 1993 606-609
33. J.R. Brubacher B. Levine R.S. Hoffman Intestinal pseudo-obstruction (Ogilvie's syndrome) in theophylline overdose Vet Hum Toxicol 38 1996 368-370
34. P. Longdon A. Henderson Intestinal pseudo-obstruction following the use of enteral charcoal and sorbitol and mechanical ventilation with papaveretum sedation for theophylline poisoning Drug Saf 7 1992 74-77
35. K.B. Goulbourne J.E. Cisek Small-bowel obstruction secondary to activated charcoal and adhesions Ann Emerg Med 24 1994 108-110
36. M.J. Ray D.R. Radin J.D. Condie et al. Charcoal bezoar. Small-bowel obstruction secondary to amitriptyline overdose therapy Dig Dis Sci 33 1988 106-107
37. W.A. Watson K.F. Cremer J.A. Chapman Gastrointestinal obstruction associated with multiple-dose activated charcoal J Emerg Med 4 1986 401-407
38. H.A. de Silva M.M. Fonseka A. Pathmeswaran et al. Multiple-dose activated charcoal for treatment of yellow oleander poisoning: A single-blind, randomised, placebo-controlled trial Lancet 361 2003 1935-1938
39. M. Tenenbein Multiple doses of activated charcoal: Time for reappraisal? Ann Emerg Med 20 1991 529-531
40. G. Levy D.M. Soda T.A. Lampman Inhibition by ice cream of the antidotal efficacy of activated charcoal Am J Hosp Pharm 32 1975 289-291
41. M. Manes J.P. Mann Easily swallowed formulations of antidote charcoals Clin Toxicol 7 1974 355-364
42. D.O. Cooney Palatability of sucrose-, sorbitol-, and saccharin-sweetened activated charcoal formulations Am J Hosp Pharm 37 1980 237-239
43. D. Dagnone D. Matsui M.J. Rieder Assessment of the palatability of vehicles for activated charcoal in pediatric volunteers Pediatr Emerg Care 18 2002 19-21
44. T.F. Eisen P.A. Grbcich P.G. Lacouture et al. The adsorption of salicylates by a milk chocolate-charcoal mixture Ann Emerg Med 20 1991 143-146
45. R.P. Navarro K.R. Navarro E.P. Krenzelok Relative efficacy and palatability of three activated charcoal mixtures Vet Hum Toxicol 22 1980 6-9
46. P.R. Gwilt D. Perrier Influence of "thickening" agents on the antidotal efficacy of activated charcoal Clin Toxicol 9 1976 89-92
47. A.H. al-Shareef D.C. Buss E.M. Allen P.A. Routledge The effects of charcoal and sorbitol (alone and in combination) on plasma theophylline concentrations after a sustained-release formulation Hum Exp Toxicol 9 1990 179-182
48. R.E. Keller R.A. Schwab E.P. Krenzelok Contribution of sorbitol combined with activated charcoal in prevention of salicylate absorption Ann Emerg Med 19 1990 654-656
49. L.K. Mathur J.M. Jaffe J.L. Colaizzi R.W. Moriarty Activated charcoal-carboxymethylcellulose gel formulation as an antidotal agent for orally ingested aspirin Am J Hosp Pharm 33 1976 717-719
50. R.M. McNamara C.K. Aaron M. Gemborys S. Davidheiser Sorbitol catharsis does not enhance efficacy of charcoal in a simulated acetaminophen overdose Ann Emerg Med 17 1988 243-246
51. G.D. Park R. Spector M.J. Goldberg et al. Effect of the surface area of activated charcoal on theophylline clearance J Clin Pharmacol 24 1984 289-292
52. H.C. Mofenson T.R. Caraccio Magnesium intoxication in a neonate from oral magnesium hydroxide laxative J Toxicol Clin Toxicol 29 1991 215-222
53. M.J. Smilkstein S.C. Smolinske K.W. Kulig B.H. Rumack Severe hypermagnesemia due to multiple-dose cathartic therapy West J Med 148 1988 208-211
54. T.A. Farley Severe hypernatremic dehydration after use of an activated charcoal-sorbitol suspension J Pediatr 109 1986 719-722
55. E.P. Krenzelok M. McGuigan P. Lheur Position statement: Ipecac syrup. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists J Toxicol Clin Toxicol 35 1997 699-709
56. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention Poison treatment in the home Pediatrics 112 2003 1182-1185
57. A. Lamminpaa J. Vilska K. Hoppu Medical charcoal for a child's poisoning at home: Availability and success of administration in Finland Hum Exp Toxicol 12 1993 29-32
58. E.J. Scharman H.A. Cloonan L.F. Durback-Morris Home administration of charcoal: Can mothers administer a therapeutic dose? J Emerg Med 21 2001 357-361
59. H.A. Spiller G.C. Rodgers Evaluation of administration of activated charcoal in the home Pediatrics 108 2001 e100
60. S. Pond M. Jacobs J. Marks et al. Treatment of digitoxin overdose with oral activated charcoal Lancet 2 1981 1177-1180
61. S.M. Pond K.R. Olson J.D. Osterloh T.G. Tong Randomized study of the treatment of phenobarbital overdose with repeated doses of activated charcoal JAMA 251 1984 3104-3108
62. P.J. Neuvonen E. Elonen M.J. Mattila Oral activated charcoal and dapsone elimination Clin Pharmacol Ther 27 1980 823-827
63. M.J. Berg W.G. Berlinger M.J. Goldberg et al. Acceleration of the body clearance of phenobarbital by oral activated charcoal N Engl J Med 307 1982 642-644
64. P. du Souich G. Caille P. Larochelle Enhancement of nadolol elimination by activated charcoal and antibiotics Clin Pharmacol Ther 33 1983 585-590
65. W.G. Berlinger R. Spector M.J. Goldberg et al. Enhancement of theophylline clearance by oral activated charcoal Clin Pharmacol Ther 33 1983 351-354
66. R.J. Hillman L.F. Prescott Treatment of salicylate poisoning with repeated oral charcoal BMJ 291 1985 1472
67. N. Honcharik S. Anthone Activated charcoal in acute cyclosporin overdose Lancet 1 1985 1051
68. S. Karkkainen P.J. Neuvonen Effect of oral charcoal and urine pH on dextropropoxyphene pharmacokinetics Int J Clin Pharmacol Ther Toxicol 23 1985 219-225
69. P.J. Neuvonen E. Elonen Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man Eur J Clin Pharmacol 17 1980 51-57
70. G. Levy Gastrointestinal clearance of drugs with activated charcoal N Engl J Med 307 1982 676-678
71. C.K. Mahutte R.J. True T.M. Michiels et al. Increased serum theophylline clearance with orally administered activated charcoal Am Rev Respir Dis 128 1983 820-822
72. B.L. Ohning M.D. Reed J.L. Blumer Continuous nasogastric administration of activated charcoal for the treatment of theophylline intoxication Pediatr Pharmacol 5 1986 241-245